Background
Health systems face a time of unprecedented change, with spiraling costs, increasing cultural disparity in access to healthcare and research, and an infrastructure that is decades old. Today, telehealth is a realistic alternative making care and research more accessible and personalised with less burden to better support the most vulnerable and under-served in our society. The ability to test and monitor for illnesses using Patient Centric micro-Sampling (PCmS) is at the centre of this reform.
Aim and main objectives
This project is designed to build upon existing pilots and knowledge, then collaborate cross-sectorially to co-create and test the logistics, infrastructure and tools required to make patient-centric microsampling a core healthcare tool and an acceptable alternative to venous blood-draw across Europe. This project aligns with many IHI’s objectives focusing on cross-sectorial collaboration, emphasizing patient and end-user- centric co-design of outputs, harmonised regulatory and data generation approaches enhancing the potential of digital innovations in healthcare, while aiming to reduce the environmental footprint during the project and in final outputs to ensure that the expected long-term impact is a reachable reality that will deliver significant benefit to the community and address unmet public health needs at scale.
To achieve our objectives, we bring together a broad group of required expertise, know-how and end-users (i.e. public and patients) to form a public-private-partnership specifically equipped to tackle this challenge. This collaborative approach where the relevant stakeholders such as healthcare professionals, regulatory agencies and patients are involved and integrated to deliver solutions and innovation across healthcare systems and ensure the best chances for success and long-term positive impact from this project.
Key deliverables include:
1) An optimized, tested and validated ‘Gold Standard’ infrastructure and workflow for patient-centric microsampling across Europe as a proven and reliable alternative to venipuncture
2) Harmonised and clear regulatory and Health Technology Assessment (HTA) pathways, standards and acceptability, measures and cost-benefit models across Europe
3) Documented evidence to draw a citable ‘line in the sand’ for future research to support decisions to integrate patient-centric microsampling into decentralised trials and care pathways
4) Stakeholder engagement and patient involvement models and research on preferences and acceptability for patient-centric microsampling
5) Foundation for future: Enable access to the developed patient-centric microsampling scientific findings, tools and assessment measures for rapid uptake and integration of patient-centric microsampling approaches into decentralised clinical studies and healthcare
Expected impact:
- Patient-centric microsampling becomes an accepted alternative to the current standard of care venipuncture and the data gathered can be leveraged in healthcare planning.
- Lowered patient burden and lowered barrier to access in situations where blood samples need to be collected, whether as part of diagnosis, care plan, health monitoring etc.
- A solution to leverage high amounts of data gathered from increased testing can be explored already in this project so that it can pave the way for future research that can improve health outcomes.
More information from the project website:
https://ihi-project-comfort.com(öffnet in neuem Fenster)
